Skip to main content
SpringerLink
Log in

Antineoplastics

Tumour lysis syndrome in an elderly patient: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Kobayashi T, Kuwai T, Yamamoto S, Kimura H, Masaki K, Hirata M, Yamaguchi A, Kouno H, Kohno H.Acute tumor lysis syndrome in the setting of advanced gastric cancer. Nihon Shokakibyo Gakkai Zasshi / Japanese Journal of Gastroenterology 109: 1372-1378, No. 8, Aug 2012 - Japan

Download references

Additional information

Key words

Cisplatin; adverse reactions; Elderly; Gimeracil/oteracil/tegafur; drug-induced; Tumour-lysis-syndrome

An event is serious (FDA MedWatch definition) when the patient outcome is: death; life-threatening; hospitalisation; disability; congenital anomaly; requires intervention to prevent permanent impairment or damage

Rights and permissions

Reprints and permissions

About this article

Cite this article

Antineoplastics. React. Wkly. 1426, 10 (2012). https://doi.org/10.2165/00128415-201214260-00034

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214260-00034

Keywords

Search

Navigation